Natixis’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-232,188
| Closed | -$4.16M | – | 1028 |
|
|
2025
Q1 | $4.16M | Buy |
232,188
+216,388
| +1,370% | +$3.88M | 0.02% | 313 |
|
|
2024
Q4 | $399K | Buy |
+15,800
| New | +$399K | ﹤0.01% | 721 |
|
|
2024
Q3 | – | Sell |
-165,500
| Closed | -$6.13M | – | 972 |
|
|
2024
Q2 | $6.13M | Sell |
165,500
-48,400
| -23% | -$1.79M | 0.04% | 265 |
|
|
2024
Q1 | $8.98M | Buy |
+213,900
| New | +$8.98M | 0.05% | 239 |
|